Stoke Therapeutics, Inc.
STOK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$88,981 | -$104,699 | -$101,067 | -$85,805 |
| Dep. & Amort. | $2,177 | $2,469 | $1,546 | $974 |
| Deferred Tax | $0 | $0 | $0 | $172 |
| Stock-Based Comp. | $27,470 | $25,257 | $22,854 | $16,450 |
| Change in WC | -$28,140 | -$6,030 | $43,023 | $46 |
| Other Non-Cash | $623 | $1,936 | $1,778 | $1,256 |
| Operating Cash Flow | -$86,851 | -$81,067 | -$31,866 | -$66,907 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$203 | -$1,616 | -$3,962 | -$1,200 |
| Net Acquisitions | $0 | $0 | $45,344 | $75,226 |
| Inv. Purchases | -$167,272 | $0 | -$201,320 | -$87,226 |
| Inv. Sales/Matur. | $60,000 | $107,562 | $159,400 | $12,000 |
| Other Inv. Act. | $0 | $0 | -$45,344 | -$75,226 |
| Investing Cash Flow | -$107,475 | $105,946 | -$45,882 | -$76,426 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $128,840 | $52,081 | $45,344 | $1,286 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,254 | $926 | $1,065 | -$2 |
| Financing Cash Flow | $131,094 | $53,007 | $46,409 | $1,284 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$63,232 | $77,886 | -$31,339 | -$142,049 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $192,011 | $114,125 | $145,464 | $287,513 |
| End Cash | $128,779 | $192,011 | $114,125 | $145,464 |
| Free Cash Flow | -$87,054 | -$82,683 | -$35,828 | -$68,107 |